[email protected]   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Radiotherapy Market Share

ID: MRFR//0997-HCR | 200 Pages | Author: Rahul Gotadki| September 2025

Introduction: Navigating the Competitive Landscape of Radiotherapy

The radiotherapy market is undergoing a revolution, with the advent of new devices, the development of the regulatory framework and the increasing demand for a personalised service. The main players, i.e. the manufacturers, the IT integrators and the AI start-ups, are competing to become the market leaders by deploying advanced digital and analytic tools, automation and IoT. The manufacturers are concentrating on improving treatment accuracy and the quality of life for patients, while the IT integrators are working on data management and interoperability. The AI start-ups are bringing about a change in the established order by offering new, innovative solutions for treatment planning and patient monitoring. The main growth areas are North America and Asia-Pacific. The strategic deployment of radiotherapy centres is moving towards green IT and green buildings. The interplay between these trends will determine the future competition and market shares. C-level managers and strategic planners must therefore be aware of these trends in order to keep up with the times.

Competitive Positioning

Full-Suite Integrators

These suppliers offer a comprehensive solution to the various stages of the radiation therapy process, from planning to treatment.

VendorCompetitive EdgeSolution FocusRegional Focus
Siemens Healthineers Innovative imaging and treatment solutions Radiotherapy systems and imaging Global
Elekta Advanced software and treatment planning Radiotherapy and oncology solutions Global
Varian Medical Systems Leading in radiation oncology technology Radiation therapy systems Global

Specialized Technology Vendors

These vendors focus on niche technologies that enhance specific aspects of radiotherapy treatment.

VendorCompetitive EdgeSolution FocusRegional Focus
Accuray Precision in radiation delivery Robotic radiosurgery systems Global
Mevion Medical Systems Compact proton therapy solutions Proton therapy systems Global
Ion Beam Applications Expertise in particle therapy Particle therapy solutions Global

Infrastructure & Equipment Providers

These vendors supply essential equipment and infrastructure that support radiotherapy practices.

VendorCompetitive EdgeSolution FocusRegional Focus
Canon Medical Systems High-quality imaging technology Medical imaging systems Global
Toshiba Medical Systems Robust imaging solutions Diagnostic imaging systems Global
Radiation Therapy Services Comprehensive service offerings Radiotherapy service provision North America

Emerging Players & Regional Champions

  • ViewRay, Inc. (USA): ViewRay, Inc., a company specializing in MRI-guided radiation therapy, recently won contracts with several leading cancer treatment centers. It is now challenging the vendors of linear irradiators by offering real-time imaging.
  • Elekta (Sweden): With its focus on advanced treatment planning software and adaptive radiotherapy solutions, it has recently implemented systems in several European hospitals, thus complementing existing suppliers and increasing treatment accuracy.
  • Accuray, the American manufacturer of the renowned CyberKnife and TomoTherapy systems, has recently extended its presence in Asia, with new facilities that provide alternatives to conventional radiotherapy and compete in terms of precision and patient comfort.
  • In Sweden, RaySearch Laboratories develops new, efficient treatment planning and workflow solutions, and has recently teamed up with British hospitals to improve operational efficiency. RaySearch is a major competitor to established software companies.
  • Sweden – C-RAD – develops solutions for the positioning and monitoring of patients on the surface. It has recently concluded contracts with German hospitals, where it complements existing systems by increasing patient safety and accuracy of treatment.

Regional Trends: In 2024 there is a notable increase in the use of advanced radiotherapy technology in North America and Europe, in line with the growing importance of individualised medicine and treatment. Emerging players focus on specialised solutions such as MRI-guided therapy and adapted radiotherapy, which gain ground in regions with a well-developed medical system. Moreover, there is a trend towards integrating software solutions that support treatment planning and patient management, indicating a trend towards more integrated oncology care.

Collaborations & M&A Movements

  • Varian Medical System and Siemens Healthineers have joined forces to integrate advanced imaging into their radiation therapy solutions, thereby improving the accuracy of the treatment and thereby strengthening their position in the oncology market.
  • In the first quarter of 2024, Elekta acquired the C-RAD software company in order to strengthen its portfolio of radiation therapy solutions and thus gain a leading position in the growing field of individualized cancer therapy.
  • Accuray and UC San Francisco have joined forces to develop new treatment strategies using the CyberKnife® system, with the goal of improving patient outcomes and strengthening their respective positions in academic medicine and clinical research.

Competitive Summary Table

CapabilityLeading PlayersRemarks
Advanced Treatment Planning Varian Medical Systems, Elekta, Accuray The Varian Eclipse system uses advanced treatment planning methods to optimize the precision of treatments. Elekta’s Monaco system, which combines the Monaco treatment planner with artificial intelligence, has been proven in clinical trials to improve the treatment outcome. Accuray’s TomoTherapy uses the helix beam to improve the distribution of dose.
Image-Guided Radiotherapy (IGRT) Siemens Healthineers, Philips Healthcare ARTISTE is a system of treatment with real-time imaging. Pinnacle, Philips' system of treatment, has the advantage of facilitating the study of the treatment and of reducing the margins of error.
Stereotactic Body Radiotherapy (SBRT) Accuray, Elekta The Accuray cyberknife is renowned for its robotic precision in the treatment of tumours in difficult positions. The Versa HD is a new, advanced system with the highest quality of beams and has been used in clinical trials for the treatment of lung and liver tumours.
Patient Management Systems Varian Medical Systems, CureMetrix Varian's ARIA platform integrates patient data management and treatment planning to simplify the workflow. CureMetrix's artificial intelligence-based solutions enhance patient monitoring and follow-up, and initial studies show improved adherence to treatment guidelines.
Radiation Safety and Quality Assurance Elekta, Sun Nuclear Corporation Quality assurance tools from Elekta are designed to ensure compliance with safety standards and are extensively validated. Sun Nuclear products are widely used and have proven to be highly effective in reducing errors.

Conclusion: Navigating the Radiotherapy Market Landscape

The radiotherapy market in 2024 will be characterized by high competition and significant fragmentation, with both established and newcomers competing for market share. The trend towards more individualized treatment approaches in the individual regions will be reflected in the strategies of the suppliers. The established companies will rely on their experience and established relationships, while newcomers will focus on new and agile business models and technologies. Artificial intelligence, automation, sustainability and operational agility will be the decisive capabilities for market leadership. The products and services of the suppliers will have to be aligned with these capabilities to achieve a sustainable competitive advantage.

Covered Aspects:
Report Attribute/Metric Details
Base Year For Estimation 2022
Historical Data 2018 - 2021
Forecast Period 2023-2030
Growth Rate  5.49% (2023-2030)
Leading companies partner with us for data-driven Insights
clients
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.